OpGen, Inc. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

GAITHERSBURG, Md., March 23, 2020 -- OpGen, Inc. (Nasdaq: OPGN) announced today that its Acuitas Lighthouse® was used in a study conducted by the Mayo Clinic to predict.

Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter. Biotech stocks went on a roller...

OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today an update on shar

Toward the end of trading Monday, the Dow traded down 10.19% to 20,822.15 while the NASDAQ fell 9.87% to 7,097.62. The S&P also fell, dropping 9.73% to 7,108.79. South Korea...

OpGen Inc (NASDAQ: OPGN) shares were ripping higher Monday in reaction to an announcement regarding a COVID-19 test kit from German molecular diagnostics company Curetis, which OpGen has agreed to m

Midway through trading Monday, the Dow traded down 7.78% to 21,381.93 while the NASDAQ fell 6.91% to 7,330.42. The S&P also fell, dropping 7.01% to 2,520.85. South Korea...

“Let’s not hurt the working people in this country that are relying on wages and tips to keep their small business going,” Nunes told Fox News. “So don’t run...

Gainers OpGen, Inc. (NASDAQ: OPGN) shares climbed 143% to $4.88 after OpGen announced Curetis, a company it is acquiring, is now offering coronavirus test kits. BioNTech SE (...

Following the market opening Monday, the Dow traded down 8.73% to 21,162.41 while the NASDAQ fell 8.26% to 7,224.07. The S&P also fell, dropping 8.10% to 2,491.38. South Korea...

OpGen, Inc. (OPGN) reported an update on the business of Curetis GmbH (“Curetis”), the other party to the planned business combination with OpGen. Today, Curetis announced that it started offerin

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 12.93%

GAITHERSBURG, Md., March 12, 2020 -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will report its fourth quarter and full year 2019.

Quorum Health (NYSE:QHC) -53%.Sasol (NYSE:SSL) -22%.Enable Midstream (NYSE:ENBL) -20%.Mesoblast (NASDAQ:MESO) -15% after 12% upmove yesterday.OpGen (NASDAQ:OPGN) -15%.Occidental Petroleum (NYSE:OXY) -

OpGen, Inc. (OPGN) announced today that shareholders of Curetis N.V. have voted to approve the business combination of Curetis GmbH and OpGen. The successful completion of the Curetis vote at their E